Contact Us

1753 South 1800 West
Woods Cross, Utah 84087
United States
Company Contact
Bill Crossman
President & CEO
860-305-6955
bill@phoenixpharmalabs.com

More »

Phoenix PharmaLabs, Inc. (PPL) is a preclinical drug discovery company focused on new non-addictive treatments for pain and opiate addiction. PPL has developed a novel family of opioid analgesics that appear to be non-addicting and free of all dangerous side effects. Studies conducted by leading institutions demonstrated analgesic potency 10x – 20x stronger than morphine; no euphoria – and therefore no abuse/addiction potential; no dysphoria; no withdrawal symptoms; only moderate signs of respiratory depression - even at 150x dosage; no death from overdose - even at 350x dose and no constipation – even at 100x dose. Please see our Biotech Showcase company profile.

www.phoenixpharmalabs.com

News Releases
Jan 6, 2016

Phoenix PharmaLabs, Inc. ("Phoenix"), announced today that Torrey Pines Institute for Molecular Studies (TPIMS) has now completed studies of the Company's advanced analog known as PPL-103 using...

More »